Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis

References

• Jemal A, Siegel R, Ward et al. Cancer statistic. CA Cancer J. Clin.56, 106–130 (2006).
   PubMed Web of Science ®Google Scholar
• Ferlay J, Bray F, Pisani P, Parkin DM. Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0, 2001. IARC Cancer Base No 5. IARC Press, Lyon, France (2001).
   Google Scholar
• Roazzi P, Capoccia R, Santaquilani M, Carrani E. EUROCARE Working Group. Electronic availability of EUROCARE-3 data. A tool for further analysis. Ann. Oncol.14, 150–155 (2003).
   Google Scholar
• Sokoloff B. Predisposition to cancer in the Bonaparte’s family. Am. J. Surg.40, 673–678 (1938).
   Google Scholar
• Correa P. Helcobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol.19, 37–43 (1995).
   Google Scholar
• Yao Y, Tao H, Park DI, Sepulveda JL, Sepulveda AR. Demonstration and characterization of mutation induced by Helicobacter pylori organisms in gastric epithelial cells. Helicobacter11, 272–286 (2006).
   PubMed Web of Science ®Google Scholar
• Harrison LE, Zhang ZF, Karpeh MS, Sun M, Kurtz RC. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case–control study in the U.S. Cancer80(6), 1021–1028 (1997).
   PubMed Web of Science ®Google Scholar
• Rocco A, Nardone G. Diet, H. pylori infection and gastric cancer: evidence and controversies. World J. Gastroenterol.13(21), 2901–2912 (2007).
   PubMed Web of Science ®Google Scholar
• Nardone G, Rocco A, Malfertheiner P. Review article: Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment. Pharmacol. Ther.20(3), 261–270 (2004).
   Google Scholar
• Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J. Cell. Physiol.211(2), 287–295 (2007).
   PubMed Web of Science ®Google Scholar
• Jones PA, Martienssen R. A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res.65(24), 11241–11246 (2005).
   PubMedGoogle Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet.33(Suppl.), 245–254 (2003).
   PubMed Web of Science ®Google Scholar
• Kim TY, Jong HS, Jung Y, Kim TY, Kang JH, Bang YJ. DNA hypermethylation in gastric cancer. Aliment. Pharmacol. Ther.20(Suppl. 1), 131–142 (2004).
   Google Scholar
• Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res.61(7), 2847–2851 (2001).
   PubMed Web of Science ®Google Scholar
• Kang JH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab. Invest.83(4), 519–526 (2003).
   PubMed Web of Science ®Google Scholar
• Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell.5, 121–125 (2004).
   PubMed Web of Science ®Google Scholar
• Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T. Identification of silencing of nine genes in human gastric cancers. Cancer Res.62, 6645–6650 (2002).
   PubMed Web of Science ®Google Scholar
• Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S,Motoyama T. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am. J. Pathol.161, 399–403 (2002).
   PubMed Web of Science ®Google Scholar
• Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS. Aberrant CpG island hypermethylation of chronic gastritis in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am. J. Pathol.163, 1551–1556 (2003).
   PubMed Web of Science ®Google Scholar
• Sato F, Meltzer SJ. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer.106(3), 483–493 (2006).
   PubMed Web of Science ®Google Scholar
• Carrozza MJ, Utley RT, Workman JL, Cote J. The diverse functions of histone acetyltransferase complexes. Trends Genet.19, 321–329 (2003).
   PubMed Web of Science ®Google Scholar
• Yang XJ. The diverse superfamily of lysine acetyltransferases and their roles in leukaemia and other diseases. Nucleic Acid Res.32, 959–976 (2004).
   PubMed Web of Science ®Google Scholar
• Neugut AI, Hayek H, Howe G. Epidemiology of gastric cancer. Semin. Oncol.23, 281–291 (1996).
   PubMed Web of Science ®Google Scholar
• Mathew A, Gangadharan P, Varghese C, Nair MK. Diet and stomach cancer: a case–control study in South India. Eur. J. Cancer Prev.9(2), 89–97 (2000).
   PubMed Web of Science ®Google Scholar
• Palli D, Russo A, Decarli A. Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy. Cancer Causes Control12(2), 163–172 (2001).
   PubMed Web of Science ®Google Scholar
• Mayne ST, Risch HA, Dubrow R et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev.10(10), 1055–1062 (2001).
   PubMed Web of Science ®Google Scholar
• Jedrychowski W, Popiela T, Steindorf K et al. Nutrient intake patterns in gastric and colorectal cancers. Int. J. Occup. Med. Environ. Health14(4), 391–395 (2001).
   PubMedGoogle Scholar
• Hamada GS, Kowalski LP, Nishimoto IN et al. Risk factors for stomach cancer in Brazil (II): a case–control study among Japanese Brazilians in Sao Paulo. Jpn J. Clin. Oncol.32(8), 284–290 (2002).
   PubMed Web of Science ®Google Scholar
• Chen H, Tucker KL, Graubard BI et al. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr. Cancer42(1), 33–40 (2002).
   PubMed Web of Science ®Google Scholar
• Milner JA. Diet and cancer: facts and controversies. Nutr. Cancer.56(2), 216–224 (2006).
   PubMed Web of Science ®Google Scholar
• Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis22(2), 91–103 (2007).
   PubMed Web of Science ®Google Scholar
• Jiang YH, Bressler J, Beaud et al. Epigenetics and human disease. Ann. Rev. Genomics Hum. Genet.5, 479–510 (2004).
   PubMed Web of Science ®Google Scholar
• Ghoshal K, Li X, Datta J et al. A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J. Nutr.136(6), 1522–1527 (2006).
   PubMed Web of Science ®Google Scholar
• Yuasa Y, Nagasaki H, Akiyama Y et al. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis26(1), 193–200 (2005).
   PubMedGoogle Scholar
• Hara M, Hanaoka T, Kobayashi M et al. Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case–control study in Japan. Nutr. Cancer46(2), 138–147 (2003).
   PubMed Web of Science ®Google Scholar
• Mu LN, Cao W, Zhang ZF et al. Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers12(1), 61–75 (2007).
   PubMed Web of Science ®Google Scholar
• Baur J, Pearson KJ, Price NL et al. Resveratrol improves health and survival on mice on an high-calorie diet. Nature444, 337–342 (2006).
   PubMed Web of Science ®Google Scholar
• Guarente L, Picard F. Calorie restriction the SIR 2 connection. Cell120, 473–482 (2005).
   PubMed Web of Science ®Google Scholar
• Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. IARC Monogr. Eval. Carcinog. Risks Hum.61, 1–241 (1994).
   PubMedGoogle Scholar
• Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med.345, 784–789 (2001).
   PubMed Web of Science ®Google Scholar
• Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut49(3), 347–353 (2001).
   PubMed Web of Science ®Google Scholar
• Nardone G, Compare D, De Colibus P, de Nucci G, Rocco A. Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. Dig. Dis.25(3), 225–229 (2007).
   PubMedGoogle Scholar
• Ushijima T, Nakajima T, Maekita T. DNA methylation as a marker for the past and future. J. Gastroenterol.41(5), 401–407 (2006).
   PubMed Web of Science ®Google Scholar
• Chan AO, Peng JZ, Lam SK et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut55(4), 463–468 (2006).
   PubMed Web of Science ®Google Scholar
• Chan AO, Lam SK, Wong BCY et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut52, 502–506 (2003).
   PubMed Web of Science ®Google Scholar
• Chan AO, Huang C, Hui WM et al. Stability of E-cadherin methylation status in gastric mucosa associated with histology changes. Aliment. Pharmacol. Ther.24(5), 831–836 (2006).
   PubMedGoogle Scholar
• Perri F, Cotugno R, Piepoli A et al. Aberrant DNA methylation in nonneoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am. J. Gastroenterol.102(7), 1361–1371 (2007).
   PubMed Web of Science ®Google Scholar
• Ushijima T. Epigenetic field for cancerization. J. Biochem. Mol. Biol.40(2), 142–150 (2007).
   PubMedGoogle Scholar
• Maekita T, Nakazawa K, Mihara M et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res.12(3), 989–995 (2006).
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Ushijima T. Diagnostic and therapeutic applications of epigenetics. Jpn J. Clin. Oncol.35(6), 293–301 (2005).
   PubMed Web of Science ®Google Scholar
• An C, Choi IS, Yao JC et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin. Cancer Res.11, 656–663 (2005).
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, Jones PA. Epigenetic in human disease and prospects for epigenetic therapy. Nature429, 457–463 (2004).
   PubMed Web of Science ®Google Scholar